Quarterly Report

Attovia Therapeutics, Inc. Filed 2026-09-02 Acc 0001193125-26-380228

Documents 1

2026-11-09 10-Q Quarterly Report
2026-09-02 10-Q Quarterly Report
2026-09-02 8-K Results of operations
2026-08-28 4/A Director bought 585,000 shares at an average $17.58 ($10,285,000)
2026-08-28 144 Sale of Securities
2026-08-28 4/A Former 10% Owner bought 585,000 shares at an average $17.58 ($10,285,000)

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

Loading atto-20260630.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…